Medicamen Biotech

Medicamen Biotech EBIT per Share

The EBIT per Share of Medicamen Biotech (MEDICAMEQ.NS) as of Oct 19, 2026 is 9.12 INR. In the previous year, EBIT per Share was 9.61 INR — a change of -5.12% (lower).

EBIT per Share

9.12INR

YoY

-5.12%

Last updated:

EBIT per Share of Medicamen Biotech is 2026 9.12 INR. EBIT per Share of Medicamen Biotech was 2025 9.61 INR. It decreases by -5.12% lower compared to the previous year.

The Medicamen Biotech EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2022
14.79 INR
Jan 1, 2023
14.42 INR
Jan 1, 2024
40.68 INR
Jan 1, 2025
9.61 INR
Jan 1, 2026
9.12 INR
Jan 1, 2027 (e)
16.85 INR
Jan 1, 2028 (e)
17.70 INR
Jan 1, 2029 (e)
20.58 INR
The Medicamen Biotech EBIT per Share history
YEAREBIT per ShareYoY
est20.58INR+16.26%
est17.70INR+5.04%
est16.85INR+84.77%
9.12INR-5.12%
9.61INR-76.37%
40.68INR+182.07%
14.42INR-2.46%
14.79INR+3.35%
14.31INR-7.66%
15.49INR+1.26%
15.30INR+21.19%
12.63INR+126.61%
5.57INR+715.23%
0.68INR+477.10%
0.12INR-40.34%
0.20INR-103.48%
-5.70INR+617.99%
-0.79INR-114.50%
5.48INR+25.81%
4.35INR+91.50%
2.27INR-6.84%
2.44INR+71.65%
1.42INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medicamen Biotech Stock analysis

What does Medicamen Biotech do? Medicamen Biotech Ltd, based in New Delhi, India, operates in the Health Care sector, specifically within Pharmaceuticals. The company manufactures and markets diverse pharmaceutical formulations, including oral solids, liquids, ointments, and injectables for both non-oncology and oncology treatments. It focuses on oncology therapeutics, cardiology, central nervous system disorders, diabetology, and pain management. With 388 employees, Medicamen Biotech produces a range of products such as tablets, capsules, syrups, and specialized oncology drugs like Abiraterone acetate and Imatinib mesylate. Medicamen Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicamen Biotech stock

EBIT per Share of Medicamen Biotech is 9.12 INR in 2026.

EBIT per Share of Medicamen Biotech changed from 9.61 INR to 9.12 INR, representing a -5.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Medicamen Biotech since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Medicamen Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Medicamen Biotech